Clinical Trial Update: Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Inetetamab in combination with Pyrotinib and oral Vinorelbine for HER2-positive metastatic breast cancer is ongoing, with st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inetetamab (inetetamab)
• Pyrotinib (pyrotinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN